|
Market Closed -
Nasdaq
04:00:00 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 253.62 USD | +1.59% |
|
+1.17% | +44.11% |
| Oct. 29 | Biogen Presents New Data Across Alzheimer?S Disease Portfolio At CTAD 2026 | CI |
| Oct. 29 | Biogen Swings Back to Growth as Stock Momentum Could Continue, RBC Says | MT |
| Market Cap | 37.49B 33.58B 30.88B 27.98B 52.31B 3,560B 53.29B 368B 148B 1,873B 141B 138B 5,905B | P/E 2026 * |
47.4x | P/E 2027 * | 22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 43.12B 38.62B 35.53B 32.19B 60.17B 4,095B 61.3B 424B 170B 2,154B 162B 158B 6,793B | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 3.78x |
| Free-Float |
85.77% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Xetra
| IDP | Delayed | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | +1.59% | ||
| 1 week | +1.17% | ||
| Current month | +12.28% | ||
| 1 month | +12.28% | ||
| 3 months | +21.97% | ||
| 6 months | +33.99% | ||
| Current year | +44.11% |
| 1 week | 243.03 |  | 258.78 |
| 1 month | 215.73 | | 258.78 |
| Current year | 160.36 | | 258.78 |
| 1 year | 148.51 | | 258.78 |
| 3 years | 110.04 | | 268.3 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2022-11-13 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 2025-02-28 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 2010-03-22 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 2009-12-31 |
William Hawkins
BRD | Director/Board Member | 72 | 2019-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/2/26 | Exercice | Controller/Auditor | 62 | 0.0000% | ||
| 9/1/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 8/4/26 | Sell | Director | -593 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.59% | +1.17% | +69.52% | +6.92% | 37.49B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.72% | +5.43% | +48.88% | +75.52% | 429.94B | |
| Weighted average by Cap. | +1.20% | +6.55% | +51.04% | +97.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.53B 9.43B 8.67B 7.86B 14.69B 1T 14.97B 103B 41.52B 526B 39.52B 38.67B 1,658B | 10.73B 9.61B 8.84B 8.01B 14.97B 1,018B 15.25B 105B 42.3B 536B 40.26B 39.4B 1,690B |
| Net income | 819M 733M 675M 611M 1.14B 77.76B 1.16B 8.05B 3.23B 40.9B 3.07B 3.01B 129B | 1.79B 1.61B 1.48B 1.34B 2.5B 170B 2.55B 17.63B 7.08B 89.61B 6.73B 6.59B 283B |
| Net Debt | 5.63B 5.05B 4.64B 4.21B 7.86B 535B 8.01B 55.35B 22.22B 281B 21.15B 20.7B 887B | 3.08B 2.76B 2.54B 2.3B 4.3B 293B 4.38B 30.27B 12.15B 154B 11.56B 11.32B 485B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | $253.62 | +1.59% | 1,303,306 |
| 26-10-29 | $249.65 | +2.29% | 1,157,854 |
| 26-10-28 | $244.05 | -3.43% | 2,493,008 |
| 26-10-27 | $252.73 | +0.19% | 1,393,391 |
| 26-10-26 | $252.26 | +0.63% | 958,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
